CD4 Count clinical trials
35 active trials name this biomarker in their eligibility criteria (recorded in the registry as “CD4 Gene”) . Describe your situation to see which ones you may be eligible for.
- Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
- Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
- IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study
- Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
- A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
- CD4CAR for CD4+ Leukemia and Lymphoma
- HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
- Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
- Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
- The DART DELIVER-02 Study
- A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
- Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
- Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
- Inflammation and Depression in People With HIV
- Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
- Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
- Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- Auto Stem Cell Transplant for Lymphoma Patients
- Observational PIC Destination Cohort
- Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
- Quantifying Radiation Induced Vaginal Stenosis
- Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
- Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Tissue Repository: CTCL Collection Protocol
- The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study
- SCOPE Analytic Treatment Interruption Protocol
- Topical Curcumin for HPV Related Cervical Disease
- CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
- A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
- Nirogacestat in Patients With Kaposi Sarcoma
- Immunologic and Virologic Parameters During Analytical Treatment Interruption Following Combination bNAb Therapy During Suppressive ART
- Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis
- Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study
- Tfh Dysfunction in HIV and Aging
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that name “CD4 Gene” in their eligibility criteria, at any level. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.